Tirzepatide 60mg/5mL is a dual-incretin peptide solution designed for research involving GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor pathways. Researchers continue to investigate its role in metabolic function, nutrient utilization, appetite signaling, and glucose homeostasis. Its dual-receptor activity provides a unique framework for studying complex metabolic mechanisms.
Lot-traced · COA on file · Sterility & mycoplasma tested
PEPTIDE DOSE: Select dose
DRAW SYRINGE TO: Select values
YOUR VIAL CONTAINS: Select values
CONCENTRATION: Select values
Tirzepatide has emerged as a significant focus in metabolic research due to its ability to activate both GIP and GLP-1 pathways. This dual-action approach enables researchers to explore interconnected biological systems involved in energy regulation and metabolic performance.
Current scientific investigations examine its influence on glucose processing, hormonal responses, satiety signaling, and body composition. As metabolic research advances, Tirzepatide continues to serve as a valuable tool for studying next-generation therapeutic pathways.
Apply once, get reviewed by our team, and access provider-only pricing across peptides, exosomes, and cellular products.
PRODUCT USAGE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product is intended strictly for laboratory research and qualifies under appropriate regulatory frameworks for research-only use. It is not intended to diagnose, treat, cure, or prevent any disease or condition. This product should only be handled by licensed, qualified professionals. It is not intended for use by the general public. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
